MoonLake Immunotherapeutics stockMLTX
MoonLake Immunotherapeutics trades at $10.80, 53.6% below its 52-week high (Jun 22, 2026). The price is below its 50- and 200-day averages, a downtrend. −18.1% year to date, +2.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 4, 2027.
Ratings, candles, signals and the screener for MLTX — after you log in
Open the terminalFrequently asked questions about MoonLake Immunotherapeutics
What is the MoonLake Immunotherapeutics stock price?
At the close on Nov 5, 2026: $10.80 (−6.57% on the day). 52-week high: $23.29 on Jun 22, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does MoonLake Immunotherapeutics report earnings?
The next quarterly report is on Mar 4, 2027. Last quarter, earnings per share changed +15% year over year, revenue 0%.
Does MoonLake Immunotherapeutics pay dividends?
No, MoonLake Immunotherapeutics does not pay dividends.
Where does MoonLake Immunotherapeutics trade and how to buy it?
Ticker MLTX, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy MoonLake Immunotherapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for MLTX are in the terminal after you log in.